Legislation successful in reducing opioid prescriptions for orbital surgeries

Posted on

There was a significant reduction in opioid prescriptions for oculoplastic and orbital surgeries after the enactment of the Michigan opioid legislation in June 2018, according to a poster presented at AAO 2020 Virtual.

In this retrospective review, patients who underwent oculoplastic and orbital surgeries before and after the legislation was in place, were compared.

A total of 88% (1316 out of 1496) of patients who underwent surgery before June 2018 were prescribed opioids compared to 50% (878 out of 1755) of patients who underwent surgery after June 2018.

Before and after the legislation enactment, prescription morphine equivalent decreased for acetaminophen/hydrocodone from 81.3 to 52.2, for tramadol from98.0 to 57.9, and for hydromorphone from 288.0 to 60.0.


Xie Y, et al. Assessing Postoperative Opioid Prescribing Patterns in Oculoplastic and Orbital Surgeries. Presented at: AAO 2020 Virtual.

Related Articles
Gail Devers Partners with the Graves’ Community to Focus on Thyroid Eye Disease
Jul 15, 2021
Gail Devers, Three-Time Olympic Gold Medalist, Partners with the Graves’ Community to FOCUS on Thyroid Eye Disease
Jul 12, 2021
Mycophenolate mofetil appears to be effective second-line treatment for TED
Jun 01, 2021